Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8404671 | 1.00 | — | — | |
| SCHEMBL377713 | 0.73 | — | — | |
| SCHEMBL8362367 | 0.73 | CA1 (0.64) | CRBNTSHRALDH1A1LMNATP53 | |
| SCHEMBL1458538 | 0.71 | — | — | |
| SCHEMBL14777333 | 0.69 | TSHR (0.44) | CRBNTSHRALDH1A1LMNATP53 | |
| SCHEMBL123182 | 0.61 | — | — | |
| SCHEMBL787862 | 0.61 | — | — | |
| SCHEMBL6852091 | 0.59 | — | — | |
| Succinimide SCHEMBL774 | 0.58 | — | — | |
| SCHEMBL1333224 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10421785-B2 | Delta receptor agonist peptides and use thereof | BAR-ILAN UNIVERSITY (IL) | 2019-09-24 | — | — | US | disclosed |
| US-20170291922-A1 | DELTA RECEPTOR AGONIST PEPTIDES AND USE THEREOF | Ariel Scientific Innovations Ltd. (IL) | 2017-10-12 | — | — | US | disclosed |
| EP-1353701-B1 | METHODS FOR PRODUCING COMPOSITIONS FOR ENHANCED DELIVERY OF BIOACTIVE MOLECULES | PR PHARMACEUTICALS INC (US) | 2011-12-21 | — | — | EP | disclosed |
| EP-2316490-A2 | Methods and compositions for enhanced delivery of bioactive molecules | PR Pharmaceuticals, Inc. (US) | 2011-05-04 | — | — | EP | disclosed |
| US-20080292712-A1 | METHODS AND COMPOSITIONS FOR ENHANCED DELIVERY OF BIOACTIVE MOLECULES | PR PHARMACEUTICALS, INC. (US) | 2008-11-27 | — | — | US | disclosed |
| US-20040185103-A1 | Methods and compositions for enhanced delivery of bioactive molecules | BROOKWOOD PHARMACEUTICALS, INC. | 2004-09-23 | — | — | US | disclosed |
| US-6706289-B2 | FOR CONTROLLED, PROLONGED RELEASE OF BIOACTIVE MOLECULES SUCH AS THERAPEUTIC PROTEINS, PEPTIDES AND OLIGONUCLEOTIDES | PR PHARMACEUTICALS, INC. | 2004-03-16 | — | — | US | disclosed |
| EP-1353701-A2 | METHODS AND COMPOSITIONS FOR ENHANCED DELIVERY OF BIOACTIVE MOLECULES | PR Pharmaceuticals, Inc. (US) | 2003-10-22 | — | — | EP | disclosed |
| US-20020155158-A1 | Methods and compositions for enhanced delivery of bioactive molecules | EVONIK CORPORATION | 2002-10-24 | — | — | US | disclosed |
| WO-2002036169-A2 | METHODS AND COMPOSITIONS FOR ENHANCED DELIVERY OF BIOACTIVE MOLECULES | PR PHARMACEUTICALS, INC. (US) | 2002-05-10 | — | — | WO | disclosed |